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Background: Falls are a serious problem for hospitalized patients, reducing the duration and quality of life. It is
estimated that over 84% of all adverse events in hospitalized patients are related to falls. Some fall risk assessment
tools have been developed and tested in environments other than those for which they were developed with
serious validity discrepancies. The aim of this review is to determine the accuracy of instruments for detecting fall
risk and predicting falls in acute hospitalized patients.
Methods: Systematic review and meta-analysis. Main databases, related websites and grey literature were searched.
Two blinded reviewers evaluated title and abstracts of the selected articles and, if they met inclusion criteria,
methodological quality was assessed in a new blinded process. Meta-analyses of diagnostic ORs (DOR) and
likelihood (LH) coefficients were performed with the random effects method. Forest plots were calculated for
sensitivity and specificity, DOR and LH. Additionally, summary ROC (SROC) curves were calculated for every analysis.
Results: Fourteen studies were selected for the review. The meta-analysis was performed with the Morse (MFS),
STRATIFY and Hendrich II Fall Risk Model scales. The STRATIFY tool provided greater diagnostic validity, with a DOR
value of 7.64 (4.86 - 12.00). A meta-regression was performed to assess the effect of average patient age over
65 years and the performance or otherwise of risk reassessments during the patient’s stay. The reassessment
showed a significant reduction in the DOR on the MFS (rDOR 0.75, 95% CI: 0.64 - 0.89, p = 0.017).
Conclusions: The STRATIFY scale was found to be the best tool for assessing the risk of falls by hospitalized
acutely-ill adults. However, the behaviour of these instruments varies considerably depending on the population
and the environment, and so their operation should be tested prior to implementation. Further studies are needed
to investigate the effect of the reassessment of these instruments with respect to hospitalized adult patients, and to
consider the real compliance by healthcare personnel with procedures related to patient safety, and in particular
concerning the prevention of falls.
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For hospitalized patients, falls are a serious problem,
reducing the duration and quality of life. Older people
with injuries have higher mortality rates and stay longer in
hospital due to comorbidity. Falls are the predominant
cause of injury in older people (over 65 years), followed by
traffic accidents, fires and burns, drowning and poisoning.
It has been reported that in the European Union there are
13.3-164.5 deaths per 100,000 persons among those older
than 65 years [1].
It is estimated that over 84% of all adverse events in hos-
pitalized patients are related to falls [2]. Approximately
30% of the hospitalized patients who fall suffer injuries, of
which 4-6% are severe, including fractures, subdural
haematomas, bleeding and even death [3].
The importance of this issue is such that the Joint
Commission International (JCI) includes it among its
safety standards in the accreditation manual for hospitals
“Reduce the risk of patient harm resulting from falls”
[4]. Furthermore, falls ranked sixth on the list of JCI
sentinel events in 2012, with 477 notifications [5], a
position among the most common adverse events it has
held for the past three years [5].
As well as the physical consequences, there are also
psychological ones, constituting what is known as the
“post-fall syndrome”, which include fear of another fall,
and the loss of self-esteem and independence, comprom-
ising the patient’s lifestyle and impacting on family
caregivers.
The costs arising from falls, particularly hip fractures,
skull fractures and leg injuries, represent a large propor-
tion of healthcare spending. It is estimated that 92% of the
costs of health care for patients who have suffered a fall
are attributable to this factor [6], although it is difficult to
obtain an accurate figure because most studies only
include the costs of patients admitted following an injury,
and do not take into account those who fall within the
hospital itself [7]. An estimate by the British National
Health Service estimated that about £15 million a year are
incurred in hospital costs as a result of falls (£92,000 per
year for an 800-bed hospital) [8].
Various studies have investigated the risk factors for falls
in hospitals [3,9], identifying these as including advanced
age, agitation, confusion or disorientation, generalized
muscle and/or leg weakness, unstable gait, urinary incon-
tinence, a history of previous falls, visual deficit or the use
of certain medications (hypnotics, sedatives, vasodilators,
diuretics, antidepressants, etc.) [3,9,10]. Moreover, the
hospital environment itself can directly affect the inci-
dence of falls. Extrinsic risk factors include the presence/
absence of bed rails, the height and stability of any type of
seat (including toilet) or obstacles in the form of clinical
furniture and equipment [11]. The mere fact of hospital-
isation represents a risk factor for falls. Older peopleespecially can become more disoriented or agitated, or
suffer diminished functionality during hospitalisation, and
thus be at increased risk of falls [12].
Analysis of the circumstances in which falls occur
among hospitalized acutely-ill patients and of the risk
factors involved has led to the development of various
instruments to assess the risk of falls, such as the
Downton scale [13], the Morse Fall Scale (MFS) [14],
the St. Thomas Risk Assessment Tool in falling elderly
inpatients (STRATIFY) [15], the Tinetti test [16], the
Conley scale [12], the Hendrich Fall Risk Model
(HFRM) [17] and its later version HFRM II [18].
Some of these risk assessment tools have been tested in
environments other than those for which they were devel-
oped [19-23], with disparate results, including difficulties
for widespread use, serious validity discrepancies between
the original authors’ version and successive ones [24], and
in the heterogeneity of diagnostic accuracy in terms of
cutoff points [22,25-27]. However, a recent Cochrane re-
view showed that multifactorial interventions in hospitals
reduce the rate of falls (rate ratio 0.69, 95% CI: 0.49 - 0.96),
although risk assessment is addressed as one of many
interventions, and it is not easy to isolate its specific effect
[28]. Hospitalized patients in the acute phase of their
disease have specific characteristics. Changes in acuity of ill-
ness and medication will affect mobility, physical status and
cognition [10], requiring a special assessment in this setting
in order to prevent falls. Moreover, an unknown environ-
ment like the hospital can contribute to increase previous
risk or generate new risk factors.
The methodological weaknesses that have been identi-
fied are subsequently reflected in the under or over-
detection of patients at risk of falling, and the routine
use of such methods may divert attention and resources
toward patients who would least benefit from preventive
measures, at the expense of those who do need them.
These considerations highlight controversies and incon-
sistencies regarding the widespread use of these tools in
the field of acute hospital care. Therefore, in order to
dispel some of these uncertainties and to determine which
of the available instruments offers better diagnostic per-
formance for fall prevention as part of a range of prevent-
ive interventions to minimise risk among hospitalized
patients, we present an up-to-date, detailed analysis of the
existing literature illustrating the scope of measures avail-
able. The results of this review will contribute to the
implementation of best practices related to preventing
falls in an acute care hospital setting.
The aim of this review is to determine the accuracy of
instruments for detecting fall risk and predicting falls in
acute hospitalized patients. The specific objectives were to
analyse the diagnostic validity and psychometric proper-
ties of the various risk assessment tools for predicting falls
in acute hospitalized patients, and to compare the
Aranda-Gallardo et al. BMC Health Services Research 2013, 13:122 Page 3 of 15
http://www.biomedcentral.com/1472-6963/13/122effectiveness of risk assessment instruments for falls and
its impact on the incidence of falls by acute hospitalized
patients.
Following the Cochrane Manual for Diagnostic Test Ac-
curacy [29], this systematic review focuses on establishing
the accuracy of instruments, scales or questionnaires
(index) developed for detecting or predicting falls (target
condition) in acute hospitalized patients, aged 16 or over
(patients).
Thus, the review determines what instruments are avail-
able for assessing the risk of falls by acute hospitalized pa-
tients, the differences among them in terms of diagnostic
accuracy and/or psychometric properties and their poten-
tial impact on preventing falls when implemented in the
clinical context.
Methods
Study design
Systematic review, performed according to the recom-
mendations of the Cochrane Handbook for Systematic
Reviews of Interventions [29], and meta-analysis. This
review focuses on three types of research papers: those
which develop diagnostic validity (DV), those which
accomplish psychometric validity (PV) and those which
evaluate the effectiveness of fall risk assessment instru-
ments (EFRA).Inclusion/exclusion criteria
1.1 Types of studies
 For DV, diagnostic validation studies of falls risk
assessment tools.
 For PV, observational studies that compare the
validity and reliability of falls risk assessment
tools.
 For EFRA, experimental studies, randomised or
not, with a control group, including the use of a
falls risk assessment tool and including
comparison data for sensitivity, specificity,
predictive values and/or likelihood ratios with
respect to other instruments or professional
clinical judgement (nurses, doctors,
physiotherapists, etc.).
 Systematic reviews of either of these
types of studies, if they meet the inclusion
criteria for participants, interventions and
outcomes.1.2 Types of participants
For any of the three types of studies, only adult
patients in acute hospitals are included:
 Adults (aged over 16 years) admitted to acute
care hospitals. Studies focusing on patients admitted to acute
psychiatric units or to paediatric units are
excluded from this review.Since this study focused on acute patients, patients
living in the community, rehabilitation hospitals or
rehabilitation units, sub-acute, long-stay patients,
institutionalized patients, did not meet the
inclusion criteria.1.3 Types of intervention
In DV and PV studies the type of intervention
criterion is not applicable. In EFRA studies,
experimental studies involving the use of a falls risk
assessment tool, either as a sole intervention or in
conjunction with others, are accepted.1.4 Types of outcome measure
In DV studies, any measure of diagnostic validity:
sensitivity, specificity, predictive values, likelihood
ratios, diagnostic Odds Ratio (DOR), area under the
curve (AUC) and frequency and distribution of risk
factors.
In PV studies, any psychometric outcome such as
reliability, internal consistency, face, criterion or
construct validity and frequency and distribution of
risk factors.
In EFRA studies: frequency of falls during patients’
stay in hospital or falls predicted, complications
resulting from falls, frequency and distribution of
risk factors identified.Search methods
The following databases were searched: MEDLINE,
CINAHL, EMBASE, WEB OF SCIENCE, SCOPUS,
COCHRANE, CRD, IME, CUIDEN PLUS, ENFISPO,
LILACS, COCHRANE PLUS, together with these re-
lated websites: PRoFaNE (Prevention of Falls Network
Europe), NSW Falls Prevention Network, Cochrane
Bone, Joint and Muscle Trauma Group and Google
Scholar. To avoid publication bias we also searched gray
literature websites Open Grey, Teseo, Dart Europe and
“Tesis Doctorales en Red” (TDR). The search languages
were English, Spanish and Portuguese and the periods
covered, from the date of the first study indexed in the
corresponding database, up to and including 31 August
2011. In addition, linked searches were made in the
references for the studies found. Search strategies are
available as an additional file (see Additional file 1).
For the searches, we used specific methodological
filters developed by the Health Information Research
Unit at McMaster University for studies of diagnostic
tools and clinical prediction rules [30,31]. Initially, the
terms used were: accidental; falls; fallers; risk assess-
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prevention; prediction; hospital units; hospitals; acute
care. In addition, we applied the terms needed to adjust
the criteria for exclusion from the review, with the
logical operator NOT (exclusion of studies in the com-
munity and those focusing on psychiatric, paediatric
and other such institutions).
Review method
The first stage of our review included a detailed assess-
ment of the titles and abstracts to determine whether each
article met the requirements for inclusion. If there was
any doubt, the full text of the article was assessed to
decide whether it met these criteria. To ensure the quality
of the process, all records were doubly evaluated, by two
blinded reviewers.
After this initial process, all the references identified as
potentially eligible were evaluated to see if they met the
inclusion criteria for the review. This process was again
carried out in parallel by two blinded reviewers. Any
discrepancies that might arise in the process were resolved
by discussion between the two evaluators, assisted by the
intervention of a third expert, not otherwise involved in
the project. Additionally, a pilot exercise was performed
with the reviewers, for application of the inclusion criteria,
on a sample of 15 items to reduce the risk of bias.
Quality appraisal
For PV studies the assessment was based on the quality
criteria identified for health questionnaires [32]. These
quality criteria addressed the content validity, internal
consistency, criterion validity, construct validity, reprodu-
cibility, longitudinal validity, responsiveness, floor and ceil-
ing effects and interpretability. For DV studies, the Critical
Appraisal Skills Programme (CASP) for diagnostic studies
was the tool selected [33]. For systematic reviews, the
PRISMA standard was used [34,35].
Data abstraction
An electronic form was used to input the results of the
studies included and evaluated, supported by the applica-
tion RevMan 5.0.24 and included the following items: clin-
ical characteristics and context of the study, participants
(number, selection, age, sex, type of disease or condition),
design, reference standard and target process, test and
comparisons, monitoring and observations. In addition,
and to obtain data for PV and EFRA studies, the following
information was included: number of items comprising
the assessment tool, number of subscales (if applicable),
type of questions (dichotomous, Likert, semantic differ-
ences, etc.), cutoff points (if any), recommendations on
training for use, recommended frequency of administra-
tion, time required for administration, reliability data,
results from factorial analysis or concurrent validity. Alsoincluded on this form were the RevMan 5.0.24 check-list
items for assessing the quality of diagnostic studies.
Furthermore, for EFRA studies, data on intervention, ran-
domisation, group allocation, follow-up and end-points
were collected.
Prior agreement will be reached on possible codes to
describe the standard outcome routines for these studies.
When the original studies did not clearly provide the
data necessary for analysis, the authors were contacted
directly for clarification or for the exact data, if possible.
Synthesis
Meta-analyses of diagnostic Odds Ratios (DOR) and
likelihood ratio (LH) coefficients were performed with
the random effects method [36]. DOR combines posi-
tive and negative likelihood ratios and it represents a
global performance measure: how greater is the odds of
having the condition among those with a positive result
with the instrument versus those ones with a negative
result [37].
Forest plots were calculated for sensitivity and specifi-
city, DOR and LH. Additionally, SROC (Summary
Receiver Operating Characteristic) curves were calcu-
lated for every analysis through the square minimum
weighted by the inverse of the variance. Heterogeneity
among studies was addressed using forest-plot diagrams
for sensitivity and specificity and the likelihood ratio
test for these two dimensions. In addition, Cochrane’s Q
statistic was calculated for the positive and negative
probability ratios, using as weights the reciprocals of the
variances and the I2 statistic. The latter value was calcu-
lated from the Q statistic (the standardised measure of
the observed heterogeneity, which is not affected by
effect size units). The heterogeneity was stratified into
three levels, following the criteria of Higgins et al. [38]:
<25% low heterogeneity, 25-50% moderate heterogen-
eity and >50% high heterogeneity.
To control the potential extra source of variability
among studies resulting from potential differences
among them regarding the thresholds for defining positive
and negative results (threshold effect), we calculated
Spearman’s correlation coefficient between sensitivity and
specificity [39]. Prior to this, we determined whether or
not the diagnostic odds ratio, using the Moses-Shapiro-
Littemberg method to decide whether the points on a
ROC curve should be adjusted symmetrically or asymmet-
rically, respectively [40]. As there was no threshold effect,
the global sensitivity and specificity were calculated. Meta-
regression models were developed introducing two co-
variables: mean age over 65 and presence/absence of risk
re-assessment along the admission period. This was
carried out for exploring additional heterogeneity sources,
by adding up co-variables to the model. The exponential
transformation of the estimated coefficients can be
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shows the change in the diagnostic performance when the
co-variable varies [41].
A concordance analysis among reviewers was carried
out during the different phases of the process and this
was subsequently incorporated into the results of the
review, using a Kappa index. For the different phases of
analysis, the applications RevMan 5.0.24, MetaDiSc 1.1.1
and PASW 18 were used.
Ethical considerations
This study deals with secondary data from original stud-
ies and therefore is not subject to the usual criteria for
original research. Nevertheless, the review participants
signed an explicit statement that there is no conflict of
interest.
Results
A search within different databases and webs produced
a total of 2,181 references (Table 1). After removing
duplicates, there remained 2,006 articles, whose titles
and abstracts were evaluated by blinded pairs of
reviewers. After this first phase, 78 articles were selected
as potentially eligible, and the full text was then read,
again by blinded pairs, to assess its quality, extract dataTable 1 Results of the bibliographic search
Source Articles located
COCHRANE PLUS 28
DARE 41
SCOPUS 122
WEB OF SCIENCE 227
LILACS 71
ENFISPO 124
CUIDEN 119
EMBASE 107
CINAHL 250
PUBMED 288
Google Scholar 554
IME 97
ProFaNe 9
Cochrane bone 3
Cochrane Library 7
Linked searches 16
Dart Europe 1
TDR 39
Open grey 3
Teseo 75
TOTAL 2181
Number of references by databases or websites.and determine its inclusion or otherwise in the meta-
analysis. Finally, 14 studies [15,20,22,23,25-27,42-48]
were selected for this review (Figure 1). A summary of
the references and the reasons for excluding the
remaining 64 items is provided in Table 2.
A total of 14,663 patients were considered in the studies
selected, although several of the latter, in addition to the
diagnostic validation of the instrument or instruments in
question, also conducted studies of intra-observer reliabil-
ity [48] inter-observer reliability [26,42,48] or the proced-
ure leading to the development of some risk assessment
scales [15,46]. A total of 13,284 patients were involved in
the analysis of diagnostic accuracy. Although not all the
studies provided the age and sex distribution of their po-
pulations, according to the published data these involved
5,504 men (41.43%) and 5,358 women (40.33%). All the
studies were performed in hospitals for acutely-ill adults.
Several of them focused on patients aged over 50 years
[45], over 65 years [15,20,44], or on hospital departmentsFigure 1 Study flow diagram.
Table 2 Summary of the causes of exclusion of rejected studies
REASON FOR EXCLUSION
Does not meet inclusion
criteria
This is not a validation study
of an instrument for assessing
the risk of falls
Provides no data or
insufficient data to
reproduce the
calculations of
diagnostic validity
It’s a comment
from another
article
The study fails
the assessment
of
methodological
quality
Language
other than
English,
Spanish or
Portuguese
Brians 1991 [49]; Browne 2004
[50]; Chow 2007 [51]; Eagle 1999
[52]; El Miedany 2011 [53];
Gerdhem 2005 [54]; Haines 2006
[55]; Haines 2007 [56]; Harrington
2010 [57]; Heinze 2006 [58];
Heinze 2009 [59]; Hendrich 1995
[17]; Hendrich 2003 [18];
Hernández 2008 [60]; Hill 2004
[61]; Jester 2005 [62]; Lee 2011
[63]; Macavoy 1996 [64]; Mertens
2007 [65]; Mertens 2010 [66];
Morse 1988 [14]; Myers 2003 [24];
Myers&Nikoletti 2003 [67];
Nakagawa 2008 [68]; Oliver 2004
[9]; Oliver 2008 [69]; O’Connell
2002 [70]; Perell 2001 [10];
Petitpierre 2010 [71]; Price 1998
[72]; Roqueta 2007 [73]; Tew 2011
[74]; Toyabe 2010 [75]; Webster
2008 [76]; Webster 2010 [77];
Yauk 2005 [78];
Cina-Tschumi 2009 [79]; Currie
2004 [80]; Echevarría 2007 [81];
Forrester 1999 [82]; Giles 2006
[83]; Hendrich 1988 [84];
Hendrich 2007 [85]; Juvé 1999
[86]; Kinn 2001 [87]; McFarlane
2004 [88]; Parker 2000 [89]; Poe
2005 [90]; Webster&Courtney
2008 [91]; Wiens 2006 [92]
Agudelo 2010 [93];
Salameh 2008 [94];
Schwendimann 2006
B [95]
Agudelo 2009
[96]; Beghe 2007
[97]; Healey
2010 [98];
Kasseroler 2009
[99]
Conley 1999 [12];
McCollam 1995
[100];
Robeywilliams
2007 [101]
Caldara 2008
[102]; Chiari
2002 [103]; Días
2006 [104];
Salarvand 2010
[105]
References of excluded studies grouped by main reason for exclusion.
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overall mean age of the patients was 69.76 years (SD 9.56).
In all cases, the diagnostic validation of the different risk
assessment tools was performed prospectively. No experi-
mental studies were conducted (Table 3).
Regarding the methodological quality of the studies,
some shortcomings were identified, mainly related to
two aspects: the lack of blinding in outcome assessment
or lack of information in this respect, and doubt as to
the representativeness of the study population, generally
because the article failed to stipulate how the sample
size was calculated (Table 4).
Although all the studies provided data enabling
reproduction of the calculations of diagnostic validation,
not all were included in the meta-analysis, because some
scales did not contain sufficient studies for this
(Figure 1). The Schmid study [46] was discarded because
it described the development of an assessment tool for
the risk of falls but this was not subsequently tested in
any of the selected studies. We also excluded the Oliver
study [15], which although it provided data on local
validation and the remote validation of the STRATIFY
scale, expressed the results in terms of ‘falls’ rather than
‘fallers’ as in all the selected studies. Therefore, and as
done by this very author in a meta-analysis of the same
scale [69], it was ruled out of our meta-analysis. With
respect to the study by Milisen [23] we only considered
the data for patients admitted to medical and surgical
units (these data are available separately), but not togeriatric units, as the latter would not meet the criteria
for inclusion in the present review, which is limited to
acutely-ill patients.
Finally, the meta-analysis was performed with the
Morse, STRATIFY and Hendrich II Fall Risk Model
instruments. The results showed that the STRATIFY tool
provided greater diagnostic validity, with a diagnostic odds
ratio (DOR) value of 7.640 (95% CI: 4.862 - 12.007) versus
5.068 (95% CI: 3.747 - 6.857) for the MFS and 3.362 (95%
CI: 2.107 - 5.364) for the HFRM II (Table 5). Figure 2
shows the forest plots with partial DOR of each study
included into the meta-analysis, as well as the global DOR
for each tool and the 95% confidence interval.
Sensitivity analyses performed for MFS showed that
after removing the Kim EAN 2007 study [26], hetero-
geneity was markedly improved, possibly because it
included younger patients (average age below 65 years),
to whom lower cutoff points were applied (25 and 51).
The same was true for the STRATIFY meta-analysis,
where, as well as the Kim EAN 2007 study [26], the data
referring to the original scale in the Barker 2011 study
[42], were also removed. In both cases, the mean age of
the study population was less than 65 years, although
the cutoff points (2 and 3) were higher than those
applied in the other study included in this meta-analysis
with similar characteristics in terms of the age of the
sample population, namely Milisen 2007 [23] (cutoff
point, 1). The removal of these two studies significantly
improved heterogeneity, although this remained high
Table 3 Characteristics of selected studies
Study Participants (n = 13284) * Study design Index and comparator test Age Men Women
Mean (SD)
(years)
n(%) n(%)
TOTAL 69.76 (9.56) * 5504 (41.43%)* 5358 (40.33%)*
Barker 2011 [42] Phase I: 263 patients. Phase II 52
patients
Prospective cross-sectional study.
Phase I: Assessment of predicitive
accuracy; phase II: Assessment on
inter-rater agreement.
The Northern Hospital Modified STRATIFY
(TNH-STRATIFY) vs STRATIFY.
61.32 (20.65) 137 (52.09%) 126 (47.91%)
Chapman 2011
[43]
1540 patients. Descriptive and comparative cross-
sectional study.
The Maine Medical Center fall risk assessment,
the New York-Presbiterian Fall and injury risk
assessment tool, Morse Fall Scale and Hendrich
II fall risk model.
n.a. n.a. n.a.
Ivziku 2011 [44] 179 patients. Descriptive prospective study. Hendrich Fall Risk Model II (HFRM II). 79.47 (9.5) 74 (41.34%) 105 (58.66%)
Kim EAN 2007
[26]
Validity study: 5489 patients.
Reliability study: 144 patients
Prospective descriptive study. Morse Fall Scale (MFS), St Thomas Risk
Assessment Tool in Falling Elderly Inpatients
(STRATIFY) and Hendrich II Fall Risk Model
(HFRM II).
55 (19) 2842 (51.78%) 2647 (48.22%)
Kim KS 2011
[27]
356 patients. Prospective cohort study. Morse Fall Scale (MFS), Bobath Memorial
Hospital Fall Risk Assessment Scale (BMFRAS),
Johns Hopkins Hospital Fall Risk Assessment
Tool (JHFRAT).
62.6 (n.a.) 201 (56.46%) 155 (43.54%)
Lovallo 2010
[45]
1148 patients. Prospective observational study. Conley Scale and Hendrich Fall Risk Model. 69 (10.33) 680 (59.23%) 468 (40.77%)
Milisen 2007
[23]
Total sample: 2568 patients; surgical
wards: 875 patients; medical wards:
1006 patients.
Prospective multicenter study. St. Thomas’s Risk Assessment Tool in Falling
Elderly Inpatients (STRATIFY).
Medical wards:
64.1 (18);
Surgical wards:
58.2 (17.1)
Medical wards:
494 (49.10%);
Surgical wards:
439 (50.17%)
Medical wards:
512 (50.9%);
Surgical wards:
436 (49.83%)
Oliver 1997 [15] Phase 1: 116 cases and 116 controls;
phase 2 (local validation): 217
patients; phase 3 (remote validation):
331 patients.
Phase 1: a prospective casecontrol
study. Phases 2 and 3: prospective
cohort study.
Development of STRATIFY. n.a. n.a. n.a.
Papaioannou
2004 [20]
620 patients. Prospective validation cohort study. Weigthed STRATIFY vs Unweighted STRATIFY. 78 (7.7) 282 (45.48%) 338 (54.52%)
Schmid 1990
[46]
Phase 1: 204 patients; phase 2: 334
patients.
Phase 1: a retrospective casecontrol
study. Phase 2: prospective cohort
study.
Development of a new fall risk assessment
tool.
n.a. n.a. n.a.
Schwendimann
2006 A [22]
386 patients. Prospective cohort study. Morse Fall Scale (MFS). 70.3 (18.5) 156 (40.41%) 230 (59.59%)
Schwendimann
2007 [25]
275 patients. Prospective cohort study. Morse Fall Scale (MFS). 80.3 (12.4) 99 (36%) 176 (64%)
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Table 3 Characteristics of selected studies (Continued)
Vassallo 2005
[47]
135 patients. Prospective, open, observational
study.
STRATIFY, Downton, Tullamore, and Tinetti. 83.8 (8.01) 49 (36.3%) 86 (63.7%)
Walsh 2010 [48] 130 inpatients in the predictive
accuracy evaluation; 25 and 35
inpatients for the intra-rater and
inter-rater reliability analyses.
Prospective cohort study of
predictive validity and observational
investigation of intra- and inter-rater
reliability.
A new instrument (Western Health Falls Risk
Assessment, WHeFRA) was compared with
‘gold standard tool’ (STRATIFY).
75 (29–94)** 51 (39.23%) 79 (60.77%)
Number of participants, study design, index and comparator test, mean age and gender of selected studies.
*Calculations with the available data.
**This study provided the age range but not SD.
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Table 4 Summary of the methodological evaluation of selected studies
Was there a
comparison with an
appropriate
reference standard?
Was there an
appropriate
spectrum of
patients?
Was there
adequate
description of
the test?
Was there
blind
outcome
assessment?
Decision to perform the
gold standard, was
independent of the test
result?
Can
likelihood
ratios be
calculated?
What was
the
accuracy of
the results?
Can the
results be
applied to
your patients?
Is the test
acceptable
in this
case?
Will the results
of the test
change your
actions?
Barker 2011 [42] + + + + + + + + + +
Chapman 2011
[43]
+ + + - + + ? ? + +
Ivziku 2011 [44] + ? + - + + + + + +
Kim EAN 2007
[26]
+ + + + + + + + + +
Kim KS 2011
[27]
+ + + - + + + + + +
Lovallo 2010
[45]
+ + + - + + + + + +
Milisen 2007
[23]
+ + + ? + + + + + +
Oliver 1997 [15] + + + + + + + + + +
Papaioannou
2004 [20]
+ + + + + + + + + +
Schmid 1990
[47]
+ ? + ? + + ? + + +
Schwendimann
2006A [22]
+ ? + - + + + + + +
Schwendimann
2007 [25]
+ ? + ? + + + + + +
Vassallo 2005
[47]
+ ? + + + + + ? + +
Walsh 2010 [48] + ? + + + + + + + +
“+”: positive evaluation; “-”: negative evaluation; “?”: no information about the item.
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Table 5 Summary of the results of the meta-analysis
STRATIFY MFS Hendrich
Sensitivity (95% CI) 0.800 (0.724 – 0.863) 0.755 (0.698 – 0.806) 0.628 (0.549 – 0.702)
Specificity (95% CI) 0.675 (0.658 – 0.692) 0.677 (0.659 – 0.695) 0.640 (0.630 – 0.651)
LH + (95% CI) 2.467 (2.047 – 2.973) 2.014 (1.800 – 2.254) 1.793 (1.500 – 2.142)
LH- (95% CI) 0.337 (0.224 – 0.507) 0.401 (0.324 – 0.498) 0.542 (0.367 – 0.802)
DOR (95% CI) 7.640 (4.862 – 12.007) 5.068 (3.747 – 6.857) 3.362 (2.107 – 5.364)
Results of sensitivity, specificity, LH+, LH- and DOR of the fall risk assessment tools with which conducted meta-analysis.
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http://www.biomedcentral.com/1472-6963/13/122for specificity and for a positive likelihood ratio (LH+),
without reaching statistical significance for the DOR.
On the HFMR II tool, heterogeneity was over 50% in
sensitivity and specificity, but was not significant for
DOR, LH + or LH-.
A meta-regression was also performed, in order to
assess the effect of average patient age over 65 years
[20,22,25,44,45,47,48] and the performance or otherwise
of risk reassessments during the patient’s stay, versus a
single evaluation on admission [27,45]. In the case of the
MFS, the reassessment showed a significant reduction
in the DOR on the tool (rDOR 0.75; 95% CI: 0.64 - 0.89,
p = 0.0176).Diagnostic Odds Ratio (DOR)
Diagnostic Odds Ratio (DOR)
Diagnostic Odds Ratio (DOR)
Figure 2 Forest plots of diagnostic odds ratio of STRATIFY, MFS Y HF
represented by the blue point and its correspondent 95% confidence inter
DOR and its 95% CI, respectively.Discussion
Although other systematic reviews and meta-analyses of
assessment tools for falls by hospitalized patients have
been performed [9,56,57,69,106], ours is the first that
includes only acute patients. This is particularly useful in
clinical practice for identifying the behaviour of the
instruments currently used exclusively in the hospital
environment, where falls are among the most frequent
adverse events [5], and thus are directly relevant to the
development and implementation of safety policies in
acute care hospitals.
Since V. Scott [106] and T.P. Haines [56] published
their systematic reviews of fall risk assessment tools inDiagnostic Odds Ratio (95% CI)
TNH-STRATIFY Barker 11   6.95 (2.79 – 17.30)
STRATIFY>=1 Milisen 07 med   9.08 (4.02 – 20.52)
STRATIFY>=1 Milisen 07 surg 23.50 (2.87 – 192.13)
MODIF-STRATIFY Papaioa 04 15.66 (4.73 – 51.80)
STRATIFY>=2 Vassallo 05        4.23 (1.59 – 11.25)
STRATIFY>=2 Walsh 10 3.41 (0.64 – 18.29)
Random Effects Model
Global DOR= 7.64 (4.86 to 12.01)
Cochran-Q= 5.10; df= 5 (p=0.4035)
Diagnostic Odds Ratio (95% CI)
MFS>=51 Chapman 11   5.67 (2.65 – 12.15)
MFS>=51 Kim KS 11 4.29 (2.41 – 7.64)
MFS>=50 Kim KS 11 4.71 (2.54 – 8.72)
MFS>=55 Schw 06 5.68 (2.84 – 11.36)
MFS>=55 Schw 07 6.04 (2.67 – 13.64)
Random Effects Model
Global DOR= 5.07 (3.75 to 6.86)
Cochran-Q= 0.74; df= 4 (p= 0.9465)
Diagnostic Odds Ratio (95% CI)
HFRM II Chapman 11   5.52 (2.52 – 12.09)
HFRM II Ivziku 11 4.53 (0.98 – 20.89)
HFRM II Kim EAN 07 3.72 (2.14 – 6.48)
HFRM II Lovallo 10 2.07 (1.22 – 3.49)
Random Effects Model
Global DOR= 3.36 (2.11 to 5.36)
Cochran-Q= 5.04; df= 3 (p=0.1692)
RM II tools. *Forest plot were DOR of each individual study is
vals. The rhombus and the scattered red lines represent the global
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ments concerning acute hospitalized patients. The
systematic review published by Oliver in 2009 focused
only on the STRATIFY tool and was not limited to acute
patients. In the present review, 9 [23,25-27,42-45,48] of
the 14 selected studies have been published since 2007,
allowing an update of knowledge available on this topic.
This is one of the strengths of this study. Another
strength of this review is that contemplated studies
assessing the psychometric properties of the fall risk
assessment instruments.
This meta-analysis was carried out as a comparison of
the Morse Fall Scale (MFS), the St. Thomas Risk Assess-
ment Tool in Falling Elderly Inpatients (STRATIFY)
and the Hendrich II Fall Risk Model (HFRM II). The re-
sults obtained showed the STRATIFY tool to be the best
tool for assessing the risk of falls among hospitalized
acutely ill adult patients, followed by MFS and finally
HFRM II. STRATIFY produced the best values for sensi-
tivity and had a specificity similar to that of MFS, and
obtained the best values for DOR. In part, these results
contradict those published in a recent meta-analysis focus-
ing on MFS and STRATIFY [57], which found a higher
sensitivity but lower specificity for the MFS with respect
to STRATIFY. However, these results did not include the
calculation of the DOR and some of the studies that were
included were excluded from our analysis as not meeting
the inclusion criteria. Moreover, we also considered
another four studies published subsequently with data for
these assessment tools [27,42,43,48].
These three tools have been compared by their simul-
taneous application in a sample of hospitalized adult pa-
tients [26]. In this study, HFRM II was found to be the
most suitable for identifying the patients at high risk of
falls, with a sensitivity of 70% and a specificity of 61.8%.
However, in the present meta-analysis, HFRM II proved
to be the worst of the three instruments considered, due
to its lower sensitivity (0.628), specificity (0.640) and
DOR (3.362).
In another study in which four risk assessment instru-
ments (STRATIFY, Tinetti, Downton and Tullamore)
were tested simultaneously in an acute patient hospital
environment [47], STRATIFY was completed most eas-
ily and in the least time; furthermore, it also presented
the best predictive validity, although it was the least
sensitive of the four. The short time required to admin-
ister this assessment scale and the fact that it is readily
understandable for medical staff are very relevant
factors in an acute hospital setting where work loads
are high and periodic reassessments of patients are
advisable.
In previous systematic reviews of this question, one of
the inclusion criteria was that the selected studies should
conduct a prospective validation of assessment tools forfalls [9,69,106]. In the systematic review and meta-analysis
carried out by Haines in 2007 [56] one of the practical im-
plications described was that although retrospective evalu-
ations are still valuable for generating initial results and
identifying the tools and cutoff points that may be useful
in clinical practice, less weight should be given to their
results than to those obtained from prospective studies,
with respect to selecting a detection tool for use in clinical
practice. In coherence with this view, all the studies in-
cluded in the present review conducted a prospective val-
idation of the various instruments examined. Nine of the
fourteen studies had been published since the completion
of the above-mentioned systematic review. Moreover, the
present analysis complies with one of the “gold standard”
criteria described by Wyatt and Altman for such scales
[107], although in none of the articles selected was a
randomised controlled trial carried out, and this may be
an area for improvement regarding the development of
future research in this field.
Previous studies have argued that fall risk assessment
performed only at the time of hospital admission does
not identify changes in the patients’ clinical status during
hospitalisation, although this is a common occurrence, es-
pecially among the elderly, who may become disoriented,
agitated or lose functionality during hospitalisation, and
thus be at greater risk of suffering a fall [12]. The acute
phase of the disease and changes in medication can affect
both mobility and the physical and cognitive status, and
therefore hospitals need an instrument that can be used
quickly and easily so that repeated assessments of these
patients may be carried out [10]. In only four of the four-
teen studies selected for this review was a reassessment
conducted, whether on a weekly schedule [15,27,46] or
following changes in the patient’s condition, after cogni-
tive impairment, after significant changes in medication
or after a fall [45]. Although the meta-regression ana-
lysis with respect to this criterion showed no effect for
HFRM II, and could not be performed for STRATIFY due
to the lack of studies in which a reassessment of patients
was performed, in the case of MFS, the reassessment pro-
duced a significant reduction in the DOR. This may be
explained, in part, as the MFS losing predictive capacity
when the risk of patients’ suffering a fall decreases, as their
condition improves. In the only study in which a reassess-
ment was carried out with MFS [27] the mean age of the
patients was below 65 years (62.6). The condition of these
younger patients would presumably improve over time,
and so their risk is more difficult to identify with this
scale. However, as discussed above, in only one of the
studies in which MFS was tested was a reassessment
performed. Thus, further research is needed, including
reassessment both with MFS and with the other instru-
ments in order to achieve a more realistic analysis of
this circumstance. It should be borne in mind that, in
Aranda-Gallardo et al. BMC Health Services Research 2013, 13:122 Page 12 of 15
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falls among hospitalized adult patients who are
subjected to external risk factors, specific to the hospital
environment and which are not taken into account by
any of the assessment instruments described.
This review and meta-analysis may also be affected by
the limitations of the primary studies analysed. First,
knowledge of the number of patients suffering a fall is
always dependent on the voluntary reporting of this fact
by the healthcare staff, and so falls may occur that are
not reported, which would to some extent invalidate
the results obtained in these studies. Second, the review
may be affected by contamination related to the imple-
mentation of other actions taken to prevent falls in the
different environments studied, and by a possible
Hawthorne effect. Moreover, limitations arise from the
questionable quality of some of the studies selected:
some offered no data on the age and/or sex distribu-
tion of the study population [15,43,46], or were defi-
cient regarding the representativeness of the sample
[22,25,44,46-48] or regarding the blinding of the re-
searchers [22,27,43-45]. Another possible limitation
concerns the search language: in the present review,
the search languages used were limited to English,
Spanish and Portuguese, and four studies were
excluded for this reason [102-105].
In short, despite the findings obtained, our analysis of
the various studies clearly shows that the behaviour of
these risk assessment instruments varies considerably
depending on the population and the environment in
which they are administered. In consequence, we can-
not recommend the generalised adoption of any single
method without its prior testing in the healthcare
setting of the intended implementation. Moreover, it
should be recalled that these instruments, or the actions
taken including their use, will not be effective if
healthcare personnel do not ensure patient safety proce-
dures are followed, and this aspect remains to be inves-
tigated in the case of falls by hospitalized patients. A
study of safety and security in Spanish hospitals
reported that the majority of healthcare staff (77.8%)
had not reported any event related to patient safety in
the past year and that 95% had reported fewer than two
such events [108]. This aspect, noted above as one of
the limitations of our study, and the question of compli-
ance by personnel with procedures established to pre-
vent adverse events, are issues which must be addressed
in order to achieve an effective culture of safety within
hospitals.
Conclusions
The STRATIFY scale was found to be the best tool for
assessing the risk of falls by hospitalized acutely-ill
adults. With this scale, the DOR was higher than withthe MFS and HFRM II. However, the behaviour of these
instruments varies considerably depending on the popu-
lation and the environment, and so their operation
should be tested prior to implementation. Further stud-
ies are needed to investigate the effect of the reassess-
ment of these instruments with respect to hospitalized
adult patients, and to consider the real compliance by
healthcare personnel with procedures related to patient
safety, and in particular concerning the prevention of
falls.
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